Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 20;13:859730. doi: 10.3389/fimmu.2022.859730

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Guo, Wang, Jiang, Tang, Liu, Cao, Hu, Chen, Luo and Bo

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The diagnostic and prognostic value of RFPL3S in TGCT. (A) Receiver operating characteristic (ROC) curve evaluated the diagnostic value of RFPL3S in distinguishing normal (N) from seminoma (SEM), normal (N) from non-seminoma (NSEM), and non-seminoma (NSEM) from seminoma (SEM) in GEO GSE3218 cohort. (B) ROC curve evaluated the diagnostic value of RFPL3S in distinguishing normal (N) form seminoma (SEM), normal (N) from non-seminoma (NSEM), and non-seminoma (NSEM) from seminoma (SEM) in TGCT cohort from TCGA. (C) Correlation between RFPL3S and disease-free interval (DFI) and progression free interval (PFI) of TGCT cohort from TCGA. Patients with high RFPL3S expression had higher DFI and PFI.